UN lifts sanctions against Gulbuddin Hekmatyar

February 5, 2017

Feb 5: The United Nations has lifted sanctions against Gulbuddin Hekmatyar, the leader of the Hezb-i-Islami group in Afghanistan and one of the most infamous figures in the country's civil war in the 1990s.

gulbuddinThe decision by the UN Security Council late on Friday follows a peace deal signed by the Afghan government and Hekmatyar's largely dormant group in September.

The accord gave Hekmatyar amnesty for past offences and granted him full political rights. It also allowed for the release of certain Hezb-i-Islami prisoners.

In a statement, the Security Council said it had dropped a freeze that had been put on Hekmatyar's assets, as well as a travel ban and an arms embargo against him.

Hekmatyar was one of the most influential leaders in the fight against Soviet forces in the 1980s. He briefly accepted the position of prime minister in an administration following the collapse of a Soviet-backed government in 1992.

Once branded as "the butcher of Kabul", Hekmatyar was accused of killing thousands of people when his fighters fired on civilian areas of the capital, Kabul, during the country's 1992-1996 civil war.

Hekmatyar's whereabouts are unknown, but Ghairat Baheer, Hezb-i-Islami's chief negotiator, told Al Jazeera that, with the sanctions now removed, he would eventually return to the Afghan capital.

"Hekmatyar is in hiding in Afghanistan, but after the UN move he will soon make an appearance in one of the provinces and will later come to Kabul," Baheer said.

The UN's decision could pave the way for other armed groups, such as the Taliban, to enter peace negotiations, according to Baheer.

He also urged the Afghan government to implement September's peace accord "completely and honestly" and called against the interference of foreign powers in Afghan affairs.

"Peace is [more] difficult to achieve than war, and we have done that, we have taken steps to achieve peace in Afghanistan," he said.

NATO forces officially ended their combat mission in December 2014. Yet, in July last year, US troops were granted greater powers to launch strikes against Taliban fighters as former President Barack Obama vowed a more aggressive campaign.

The US still has about 8,400 troops in the country.

Habiburrahman Hekmatyar, son of Gulbuddin Hekmatyar, hailed the lifting of the sanctions as "a very big decision that will change the entire situation of Afghanistan".

"Every Afghan has suffered through decades of war and conflict, and everyone has sacrificed a lot in this war, including us, so I urge every Afghan to look forward and believe that we are working towards peace," he told Al Jazeera.

But others, including human rights groups and ordinary Afghans, criticised the peace accord and the subsequent lifting of the sanctions against Hekmatyar.

"He just wants to have a political position for his family and for his party members in Afghanistan. He is the killer of the people of Afghanistan, it will be difficult to change this point of view of people about him," Sami Darayi, a Kabul resident who lost his uncle in the civil war, told Al Jazeera on Saturday.

"He did not even apologise to us Afghans, he never said he committed a mistake by killing innocent people."

Others, like Kabul-based Khalid Amini, who lost his father by one of the Hekmatyar's fighters, told Al Jazeera that "as long as it brings peace in the country, I have no problem with him making a return".

"I remember my father's death, but I want to look forward, I want to look after my family and live in a peaceful environment. So, I want peace and he should bring that to the country now," he said.

Many foreign governments, including the US, praised the accord at the time as a step towards wider peace in Afghanistan.

But Human Right Watch, a New York-based watchdog, had branded Hekmatyar "one of Afghanistan's most notorious war crimes suspects" and said his return would "compound a culture of impunity" that has denied justice to the many victims of his forces.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 15,2020

Washington, Jul 15: The Trump administration has agreed to rescind its July 6 rule, which temporarily barred international students from staying in the United States unless they attend at least one in-person course, a federal district court judge said on Tuesday.

The U-turn by the Trump administration comes following a nationwide outrage against its July 6 order and a series of lawsuits filed by a large number of educational institutions, led by the prestigious Harvard University and Massachusetts Institute of Technology (MIT), seeking a permanent injunctive relief to bar the Department of Homeland Security (DHS) and the US Immigration and Customs Enforcement (ICE) from enforcing the federal guidelines barring international students attending colleges and universities offering only online courses from staying in the country.

As many as 17 US states and the District of Columbia, along with top American IT companies such as Google, Facebook and Microsoft, joined MIT and Harvard in the US District Court in Massachusetts against the DHS and the ICE in seeking an injunction to stop the entire rule from going into effect.

"I have been informed by the parties that they have come to a resolution. They will return to the status quo," Judge Allison Burroughs, the federal district judge in Boston, said in a surprise statement at the top of the hearing on the lawsuit.

The announcement comes as a big relief to international students, including those from India. In the 2018-2019 academic year, there were over 10 lakh international students in the US. According to a recent report of the Student and Exchange Visitor Program (SEVP), 1,94,556 Indian students were enrolled in various academic institutions in the US in January.

Judge Burroughs said the policy would apply nationwide.

"Both the policy directive and the frequently asked questions would not be enforced anyplace," she said, referring to the agreement between the US government and MIT and Harvard.

Congressman Brad Scneider said this is a great win for international students, colleges and common sense.

"The Administration needs to give us a plan to tackle our public health crisis - it can't be recklessly creating rules one day and rescinding them the next," he said in a tweet.

Last week, more than 136 Congressmen and 30 senators wrote to the Trump administration to rescind its order on international students.

"This is a major victory for the students, organisers and institutions of higher education in the #MA7 and all across the country that stood up and fought back against this racist and xenophobic rule," said Congresswoman Ayanna Pressley.

"Taking online classes shouldn't force international students out of our country," Congressman Mikie Sherrill said in a tweet.

In its July 6 notice, the ICE had said all student visa holders, whose university curricula were only offered online, "must depart the country or take other measures, such as transferring to a school with in-person instruction to remain in lawful status".

"If not, they may face immigration consequences, including but not limited to the initiation of removal proceedings," it had said.

In their lawsuit, the 17 states and the District of Columbia said for many international students, remote learning in the countries and communities they come from would impede their studies or be simply impossible.

The lawsuit alleged that the new rule imposes a significant economic harm by precluding thousands of international students from coming to and residing in the US and finding employment in fields such as science, technology, biotechnology, healthcare, business and finance, and education, and contributing to the overall economy.

In a separate filing, companies like Google, Facebook and Microsoft, along with the US Chamber of Commerce and other IT advocacy groups, asserted that the July 6 ICE directive will disrupt their recruiting plans, making it impossible to bring on board international students that businesses, including the amici, had planned to hire, and disturb the recruiting process on which the firms have relied on to identify and train their future employees.

The July 6 directive will make it impossible for a large number of international students to participate in the CPT and OPT programmes. The US will "nonsensically be sending...these graduates away to work for our global competitors and compete against us...instead of capitalising on the investment in their education here in the US", they said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 27,2020

Geneva, May 27: The number of confirmed cases of COVID-19 worldwide has increased by nearly 100,000 over the past 24 hours to surpass 5.4 million, the World Health Organisation (WHO) said.

According to the WHO, the global case tally currently stands at 5,404,512 -- a rise by 99,780 over the past day.

The death count worldwide amounts to 343,514 -- an increase by 1,486.

Most cases of infection are recorded in the Americas -- 2,454,452, with 143,739 deaths.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.